6-Methoxy-1,2,3,4-tetrahydro-beta-carboline: a specific monoamine oxidase-A inhibitor in CF-1 mouse brain. 1980

D L Sparks, and N S Buckholtz

The activities of monoamine oxidase (MAO)-A and MAO-B (using [3H]serotonin and [14C]beta-phenylethylamine, respectively, as substrates) were determined in homogenates of whole mouse brains using a solvent extraction procedure. 6-Methoxy-1,2,3,4-tetrahydro-beta-carboline (6-MeO-TH beta C) had an IC50 of 1.6 microM, in vitro, for MAO-A using whole brain homogenate. A time course of apparent in vivo MAO-A inhibition using 6-MeO-TH beta C (100 mg/kg i.p.) showed a maximal inhibition by 1 h (56%), a decline to 30% at 12 h, and no inhibition at 24 h. There was a maximal inhibition of MAO-B by 4 h (16%). A dose-effect study done at 1 h after injection showed 6-MeO-TH beta C to inhibit MAO-A by 23% at 25 mg/kg, 43% at 50 mg/kg, 58% at 100 mg/kg and 73% at 150 mg/kg; for MAO-B there was no inhibition at 25 and 50 mg/kg and 16% inhibition at 100 mg/kg. The data thus indicate that, at doses less than or equal to 50 mg/kg, 6-MeO-TH beta C is a specific MAO-A inhibitor in vivo.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002243 Carbolines A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles. Carboline,Pyrido(4,3-b)Indole,Beta-Carbolines,Pyrido(4,3-b)Indoles,Beta Carbolines
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D L Sparks, and N S Buckholtz
May 1984, Acta pharmacologica et toxicologica,
D L Sparks, and N S Buckholtz
October 1975, Research communications in chemical pathology and pharmacology,
D L Sparks, and N S Buckholtz
April 1972, Journal of neurochemistry,
D L Sparks, and N S Buckholtz
October 1997, Planta medica,
D L Sparks, and N S Buckholtz
April 1973, Canadian journal of biochemistry,
D L Sparks, and N S Buckholtz
January 1995, Journal of neural transmission. Supplementum,
Copied contents to your clipboard!